DrugPatentWatch Database Preview
Details for Patent: 10,005,761
Which drugs does patent 10,005,761 protect, and when does it expire?
Patent 10,005,761 protects BRAFTOVI and MEKTOVI and is included in two NDAs.
This patent has sixty-seven patent family members in forty-three countries.
Summary for Patent: 10,005,761
| Title: | Compounds and compositions as protein kinase inhibitors |
| Abstract: | The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf. |
| Inventor(s): | Huang; Shenlin (San Diego, CA), Jin; Xianming (San Ramon, CA), Liu; Zuosheng (San Diego, CA), Poon; Daniel (Piedmont, CA), Tellew; John (La Jolla, CA), Wan; Yongqin (Irvine, CA), Wang; Xing (San Diego, CA), Xie; Yongping (San Diego, CA) |
| Assignee: | Array BioPharma Inc. (Boulder, CO) |
| Application Number: | 15/070,905 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,005,761
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-001 | Jun 27, 2018 | DISCN | Yes | No | Start Trial | Start Trial | TREATMENT OF MELANOMA | Start Trial | ||||
| Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-002 | Jun 27, 2018 | RX | Yes | Yes | Start Trial | Start Trial | TREATMENT OF MELANOMA | Start Trial | ||||
| Array Biopharma Inc | MEKTOVI | binimetinib | TABLET;ORAL | 210498-001 | Jun 27, 2018 | RX | Yes | Yes | Start Trial | Start Trial | INDICATED IN COMBINATION WITH ENCORAFENIB FOR THE TREATMENT OF MELANOMA | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,005,761
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 077975 | Start Trial | |||
| Australia | 2010286569 | Start Trial | |||
| Canada | 2771775 | Start Trial | |||
| China | 102725283 | Start Trial | |||
| China | 103896921 | Start Trial | |||
| Colombia | 6612222 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
